Two Clinically Implementable Digital PCR Assessments of DNA Methylation for Diagnosing Heavy Alcohol Consumption

Area of Science:

• Biochemistry
• Genetics
• Clinical Medicine

Background:

• Heavy alcohol consumption (HAC) significantly impacts health.
• Current clinical tools for diagnosing HAC are limited, lacking easy implementation and effective biological measures.
• Existing biological markers for HAC do not fully meet clinical needs.

Purpose of the Study:

• To review existing biological measures for HAC, detailing their advantages and disadvantages.
• To examine the theory and performance of novel methylation-sensitive digital PCR (MSdPCR) assays: Alcohol T Score (ATS) for chronic HAC and ZSCAN25 for recent HAC.
• To propose a framework for enhancing the clinical diagnosis and management of alcohol use disorders using these new epigenetic markers.

Main Methods:

• Review of existing literature on biological measures for HAC.
• Analysis of the underlying theory and performance characteristics of MSdPCR assays (ATS and ZSCAN25).
• Development of a proposed clinical paradigm integrating new epigenetic markers.

Main Results:

• Existing biological measures for HAC have limitations in clinical utility.
• MSdPCR assays (ATS and ZSCAN25) offer potential for assessing chronic and recent HAC, respectively.
• These novel epigenetic markers can potentially improve the diagnosis and management of alcohol use disorders.

Conclusions:

• Epigenetic tools like ATS and ZSCAN25 show potential for assessing alcohol consumption.
• Further research is necessary to validate the performance of these epigenetic tools in diverse populations.
• These tools may offer a more objective approach to diagnosing and managing alcohol use disorders.